Marshall Wace’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Marshall Wace’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4M	Buy	+1,231,946	New	+$2.51M	﹤0.01%	1753
2024 Q3	–	Sell	-14,064	Closed	-$23.5K	–	2715
2024 Q2	$23.5K	Sell	14,064 -57,024	-80%	-$102K	﹤0.01%	2468
2024 Q1	$132K	Buy	+71,088	New	+$131K	﹤0.01%	2279
2022 Q3	–	Sell	-104,478	Closed	-$1.18M	–	3548
2022 Q2	$1.18M	Buy	+104,478	New	+$1.25M	﹤0.01%	2344
2022 Q1	–	Sell	-12,820	Closed	-$606K	–	3639
2021 Q4	$606K	Buy	+12,820	New	+$769K	﹤0.01%	2705
2021 Q2	–	Sell	-53,596	Closed	-$2.6M	–	2836
2021 Q1	$2.6M	Sell	53,596 -97,289	-64%	-$5.28M	0.01%	1182
2020 Q4	$7.11M	Buy	150,885 +76,288	+102%	+$3M	0.04%	450
2020 Q3	$3.51M	Buy	+74,597	New	+$2.46M	0.02%	635

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Marshall Wace's NBP Position: Q2 2026 in Review

Marshall Wace opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 1,231,946 shares worth $2.4M. The stake represents ﹤0.01% of the portfolio and ranks #1753 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NBP as recently as Q2 2024.

Marshall Wace first reported a position in NBP in Q3 2020 and has held it in 8 quarters since. The position peaked at $7.11M in Q4 2020. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Marshall Wace held 1,231,946 shares of NovaBridge Biosciences American Depositary Shares worth $2.4M as of Q2 2026.
NovaBridge Biosciences American Depositary Shares was a new Marshall Wace position in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1753 holding.
Marshall Wace first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 8 quarters since.
Marshall Wace's NovaBridge Biosciences American Depositary Shares position peaked at $7.11M in Q4 2020.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.